Mimedx (MDXG) EPS (Weighted Average and Diluted) Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.90% |
| Dec 31, 2025 | 20.95% |
| Sep 30, 2025 | 17.39% |
| Jun 30, 2025 | 22.42% |
| Mar 31, 2025 | 26.58% |
| Dec 31, 2024 | 22.10% |
| Sep 30, 2024 | -14.59% |
| Jun 30, 2024 | 22.42% |
| Mar 31, 2024 | 20.11% |
| Dec 31, 2023 | 25.30% |
| Sep 30, 2023 | 106.68% |
| Jun 30, 2023 | -12.94% |
| Mar 31, 2023 | -28.47% |
| Dec 31, 2022 | 11.84% |
| Sep 30, 2022 | -17.54% |
| Jun 30, 2022 | -26.37% |
| Mar 31, 2022 | -33.24% |
| Dec 31, 2021 | -19.14% |
| Sep 30, 2021 | -27.23% |
| Jun 30, 2021 | -28.47% |
| Mar 31, 2021 | -61.54% |
| Dec 31, 2020 | -28.81% |
| Sep 30, 2020 | -58.49% |
| Jun 30, 2020 | -29.20% |
| Mar 31, 2020 | -24.57% |
| Dec 31, 2019 | -34.08% |
| Sep 30, 2019 | 29.67% |
| Jun 30, 2019 | -112.47% |
| Mar 31, 2019 | -64.38% |
| Dec 31, 2018 | -102.44% |
| Sep 30, 2018 | 11.92% |
| Jun 30, 2018 | 31.95% |
| Mar 31, 2018 | 31.95% |
| Dec 31, 2017 | 43.10% |
| Sep 30, 2017 | 56.54% |
| Jun 30, 2017 | 61.54% |
| Mar 31, 2017 | 47.58% |